Paydirt
BIOA
Ticker

BioAge Labs, Inc.

BIOA · Healthcare · BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases

BioAge Labs, Inc. (BIOA), in the Healthcare sector, has 8 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 0 purchases and 8 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Jun 30 and filed Jul 1. The most active filer was Paul D Rubin with 5 filings.

Add to watchlist
Filings, ttm
8
0 buys · 8 sells
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$7.6M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Jun 30
Filed Jul 1
ADViAverage daily dollar volume
$8.8M
market data
Share price · 12M
$9.38 (+83.6%)
$25.10$15.02$4.94Sep 22 2025Mar 10Aug 24

Adjusted for splits and dividends.

Volume by month
$12.4M$6.2M$0Oct 2024Apr 2025Oct 2025Apr 2026Oct 2024 · buys $12.4MDec 2025 · sells $918KJan 2026 · sells $4.6MFeb 2026 · sells $139KMar 2026 · sells $151KApr 2026 · sells $157KJul 2026 · sells $1.6M
Buys $12.4M Sells $7.6M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
PR Paul D Rubin Chief Medical Officer 5 filings VP Vijay Satyanand Pande Director 2 filings SB Shane Barton Principal Accounting Officer 1 filing BC Bihua Chen Other 1 filing PE Patrick G Enright Director 1 filing KF Kristen Fortney Chief Executive Officer 1 filing DG Dov A Md Goldstein Chief Financial Officer 1 filing JH James Healy Director 1 filing
Recent filings
Shane BartonSALE Principal Accounting Officer $1.6M
62,566 sh across 2 lots
Exec Jun 29
Filed Jul 1 · 4:27 PM ET
Paul D RubinSALE Chief Medical Officer $157K
8,820 sh × $17.81
Exec Apr 1
Filed Apr 3 · 5:30 PM ET
Paul D RubinSALE Chief Medical Officer $151K
7,433 sh × $20.30
Exec Mar 2
Filed Mar 3 · 5:30 PM ET
Paul D RubinSALE Chief Medical Officer $139K
7,433 sh × $18.75
Exec Feb 2
Filed Feb 3 · 5:30 PM ET
Kristen FortneySALE Chief Executive Officer $4.2M
233,107 sh × $18.12
Exec Jan 13
Filed Jan 15 · 5:30 PM ET
Dov A Md GoldsteinSALE Chief Financial Officer $405K
20,637 sh across 2 lots
Exec Jan 13
Filed Jan 15 · 5:30 PM ET
Paul D RubinSALE Chief Medical Officer $216K
18,000 sh × $12.00
Exec Dec 9 2025
Filed Dec 11 2025 · 5:30 PM ET
Paul D RubinSALE Chief Medical Officer $702K
68,897 sh × $10.19
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET
Vijay Satyanand PandePURCHASE Director $4.3M
219,195 sh across 3 lots
Exec Oct 1 2024
Filed Oct 3 2024 · 5:30 PM ET
Bihua ChenPURCHASE Other $8.1M
450,000 sh × $18.00
Exec Sep 27 2024
Filed Oct 1 2024 · 5:30 PM ET
James HealyPURCHASE Director $12.0M
666,665 sh across 5 lots
Exec Sep 27 2024
Filed Sep 27 2024 · 5:30 PM ET
Patrick G EnrightPURCHASE Director $7.2M
400,000 sh × $18.00
Exec Sep 27 2024
Filed Sep 27 2024 · 5:30 PM ET
Vijay Satyanand PandePURCHASE Director $16.2M
900,000 sh × $18.00
Exec Sep 27 2024
Filed Sep 27 2024 · 5:30 PM ET